Association between state-specific reimbursement and Medicaid acceptance for Mohs micrographic surgery.
Published in Journal of the American Academy of Dermatology
Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursem...
Published in Value in health regional issues
This study aimed to describe the process of the institutionalization of health technology assessment (HTA) in Jordan. In particular, this study presents local policy perspectives on capacity building for HTA and the progress made toward its use in pricing and reimbursement decisions. University-based education and professional development training ...
New Evaluation and Management Code Level Selection Trends in Hip and Knee Osteoarthritis Patients.
Published in The Journal of arthroplasty
On January 1, 2021, the American Medical Association implemented changes regarding the outpatient Evaluation and Management (E/M) criteria dictating Current Procedural Terminology code level selection to help diminish administrative burden and emphasize medical decision-making as the primary determinant in E/M level of service (EML). The goal of th...
"Funds Flow" Implementation at Academic Health Centers: Unique Challenges to Pediatric Departments.
Published in The Journal of pediatrics
Outcome-based reimbursement in Central-Eastern Europe and Middle-East
...
Published in Frontiers in Medicine
Outcome-based reimbursement models can effectively reduce the financial risk to health care payers in cases when there is important uncertainty or heterogeneity regarding the clinical value of health technologies. Still, health care payers in lower income countries rely mainly on financial based agreements to manage uncertainties associated with ne...
Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (...
Published in Frontiers in Medical Technology
The evaluation of pharmaceutical innovation and therapeutic value is an increasingly complex exercise for which different approaches are adopted at the national level, despite the need for standardisation of processes and harmonisation of public health decisions. The objective of our analysis was to compare the approaches of the AIFA (Agenzia Itali...
The German Fast Track Toward Reimbursement of Digital Health Applications (DiGA): Opportunities and Challenges for Manuf...
...Published in Journal of diabetes science and technology
Digital health applications (DiGA) supporting the management of diabetes are among the most commonly available digital health technologies. However, transparent quality assurance of DiGA and clinical proof of a positive healthcare effect is often missing, which creates skepticism of some stakeholders regarding the usage and reimbursement of these a...
Coverage with evidence development for medical devices in Europe: Can practice meet theory?
Published in Health economics
Health economists have written extensively on the design and implementation of coverage with evidence development (CED) schemes and have proposed theoretical frameworks based on cost-effectiveness modeling and value of information analysis. CED may aid decision-makers when there is uncertainty about the (cost-)effectiveness of a new health technolo...
Optimizing the nutrition support care model: Analysis of survey data.
...Published in JPEN. Journal of parenteral and enteral nutrition
Malnutrition is underrecognized and underdiagnosed, despite high prevalence rates and associated poor clinical outcomes. The involvement of clinical nutrition experts, especially physicians, in the care of high-risk patients with malnutrition remains low despite evidence demonstrating lower complication rates with nutrition support team (NST) manag...
Influence of medical comorbidity and surgical indication on total elbow arthroplasty cost of care.
...Published in Journal of shoulder and elbow surgery
Movement toward providing value-based musculoskeletal care requires understanding the cost associated with surgical care as well as the drivers of these costs. The aim of this study was to investigate the effect of common medical comorbidities and specific total elbow arthroplasty (TEA) indications on reimbursement costs throughout the 90-day TEA e...
